61 min listen
Biotech Solution to Citrus Greening Disease; Your Questions Answered
Biotech Solution to Citrus Greening Disease; Your Questions Answered
ratings:
Length:
61 minutes
Released:
Aug 29, 2015
Format:
Podcast episode
Description
This week’s Talking Biotech features discussion of Huanglongbing (HLB) also known as Citrus Greening Disease. The disease is devastating Florida citrus, and is causing a massive hardship on the State’s iconic industries. We are joined by Ricke Kress from Southern Gardens Citrus, one of the largest producers and processors. Southern Gardens has experienced massive losses from citrus greening, losing over 800,000 trees. They are now in the process of deregulating the first genetically engineered citrus variety. A gene from spinach moved to citrus trees confers tolerance to this disease, and the plants are asymptomatic and productive so far. This is another excellent example of how these technologies, developed by small companies or universities, can solve issues that help ensure future delivery of fresh, healthy fruit.# COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
Released:
Aug 29, 2015
Format:
Podcast episode
Titles in the series (100)
Biotechnology in Uganda; Reflections on a Public Discussion: This week features two discussions with fellows serving in the Global Leadership Program of the Cornell Alliance for Science. The first part is a discussion with Nassib Mugwanya, Outreach Leader for the Ugandan Biosciences Information Center. He discuss by Talking Biotech with Dr. Kevin Folta